Express Pharma
Home  »  Pharma Ally  »  TAKE Solutions’ product pharmaREADY achieves 100th customer win

TAKE Solutions’ product pharmaREADY achieves 100th customer win


TAKE Solutions announced that it has achieved its landmark 100th customer win for pharmaREADY, its fully integrated, regulatory compliant, web-based product suite.

This flagship product suite was launched in the market in 2005, evolving over the years through 10 major update releases, and now caters to 100 global customers across North America, Europe, Middle East, Australia, China & India. pharmaREADY clients include Microlabs, Aurobindo Pharma, Piramal Enterprise, Intas Pharma, Macleods Pharma and Manipal College of Pharmaceutical Sciences (MCOPS).

pharmaREADY is a cloud or on premise regulatory suite comprised of Document Management, Training Records Management, Structured Product Labelling and Electronic Common Technical Document (eCTD) Publishing Solutions. Reportedly, the solution simplifies the complex process of creating, viewing, and managing drug approval submissions to Health Authorities like US-FDA, Health Canada, European Medicines Authority, Swiss Medic, Saudi FDA, Australia and South Africa.

Ram Yeleswarapu, President & CEO, TAKE Solutions said, “We are extremely proud to mark this important milestone of 100 successful deployments. The key to pharmaREADY’s success since its launch over a decade ago is its intuitive and easy to use workability. We continue to make significant strides towards achieving our vision of improving outcomes with pharmaREADY, with 97 per cent customer retention since 2015.  Backed by this momentum, we look forward to scripting more success stories with our product in the future. ’’

In a recently conducted customer satisfaction survey, TAKE reported that all its customers expressed immense satisfaction with the 24*7 customer support provided and most expressed willingness to refer PharmaReady to others, enabling successful cross selling.

Contact Details:
Samhita Suresh
TAKE Solutions
Tel: +91 44 2435 7359/ 60
Email: [email protected]

Comments are closed.